Patents by Inventor Breian Knudsen

Breian Knudsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Formulation Comprising Metformin and Repaglinide
    Publication number: 20140066482
    Abstract: The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 6, 2014
    Applicant: Novo Nordisk A/S
    Inventors: Bent Hoejgaard, Breian Knudsen, Stella Rudkjaer Rasmussen, Lene Orup Jacobsen
  • Pharmaceutical Formulation Comprising Metformin and Repaglinide
    Publication number: 20110294852
    Abstract: The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation.
    Type: Application
    Filed: August 9, 2011
    Publication date: December 1, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Bent Højgaard, Breian Knudsen, Stella Rudkjær Rasmussen, Lene Orup Jacobsen
  • Pharmaceutical Formulation Comprising Metformin and Repaglinide
    Publication number: 20100029721
    Abstract: The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation.
    Type: Application
    Filed: September 28, 2007
    Publication date: February 4, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Bent Hojgaard, Breian Knudsen, Stella Rudkjaer Rasmussen, Lene Orup Jacobsen
  • Novel tablets and capsules and a process for its preparation
    Publication number: 20050070536
    Abstract: Tablets and capsules can be prepared with improved homogenous distribution of the active ingredient if microcrystalline cellulose and silicon dioxide are used as some of the starting materials.
    Type: Application
    Filed: November 10, 2004
    Publication date: March 31, 2005
    Inventors: Thyge Hjorth, Breian Knudsen
  • Novel tablets and capsules and a process for its preparation
    Publication number: 20030050312
    Abstract: Tablets and capsules wherein the content of active ingredient in the tablet or capsule is not more than about 3% (weight/weight) can be prepared if microcrystalline cellulose and silicon dioxide are used as some of the starting materials.
    Type: Application
    Filed: March 12, 2002
    Publication date: March 13, 2003
    Inventors: Thyge Borup Hjorth, Breian Knudsen
  • Pharmaceutical composition and the process for its preparation
    Publication number: 20010046990
    Abstract: A new stable pharmaceutical composition containing (−) 3-[4-[2-Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid as active ingredient is provided, as well as process methods and formulations.
    Type: Application
    Filed: April 4, 2001
    Publication date: November 29, 2001
    Inventors: Thyge Borup Hjorth, Breian Knudsen
  • Compressible enzyme powder
    Patent number: 5885618
    Abstract: This invention relates to a directly compressible enzyme powder produced by mixing a liquid enzyme preparation with a suitable carrier, using the principle of wet granulation, whereby the step of freeze drying and spray-drying is avoided. The resulting enzyme powder has extraordinary good compression qualities and may directly be tabletted.
    Type: Grant
    Filed: November 28, 1995
    Date of Patent: March 23, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Inge Helmer Knap, Breian Knudsen